Blood News and Research

RSS

No link between low-level electromagnetic field exposure from mobile phones and health risks

There is no scientific evidence that low-level electromagnetic field exposure from mobile phones and other transmitting devices causes adverse health effects, according to a report presented by a Norwegian Expert Committee. In addition, the Committee provides advice to authorities about risk management and regulatory practice.

18 Sep 2012

ProImmune launches ProStorm in vitro cytokine release assay

ProImmune Ltd., a leader in services for understanding immune responses, announced today the commercial launch of ProStorm, an in vitro cytokine release assay, which can help assess the likelihood of first infusion reactions to novel therapeutics.

18 Sep 2012

Fall prediction and prevention technology: an interview with Rob Goudswaard and Heribert Baldus from Philips

Falls in the elderly are a major health problem. It is has emerged from data in the US that roughly 1 in 3 people over 65 fall at least once a year. Half of them experience the same again the next year.

18 Sep 2012

Two abnormalities associated with cystic fibrosis-related diabetes

A new University of Iowa study suggests there are two root causes of a type of diabetes associated with cystic fibrosis (CF). The findings, which already have sparked a clinical trial, may guide development of new treatments or even help prevent diabetes in patients with CF.

18 Sep 2012

Researchers to probe causes, treatments of toxic reactions in blood plasma

In the largest undertaking of its kind, scientists at four leading U.S. research institutions are embarking upon a five-year National Institutes of Health (NIH)-funded study to make blood transfusions safer and more effective by uncovering the exact causes of hemoglobin toxicity.

18 Sep 2012

Positive data from Aprea’s APR-246 Phase I/II study on blood or prostate cancer

Aprea today announced positive data from a completed Phase I/II clinical study with its investigational drug APR-246. The results from the study have been published in the Journal of Clinical Oncology.

18 Sep 2012

New light-based technique demonstrates that toxic proteins build up gradually in blood cells

A new light-based technique for measuring levels of the toxic protein that causes Huntington's disease (HD) has been used to demonstrate that the protein builds up gradually in blood cells. Published today (17th) in the Journal of Clinical Investigation, the findings shed light on how the protein causes damage in the brain, and could be useful for monitoring the progression of HD, or testing new drugs aimed at suppressing production of the harmful protein.

18 Sep 2012

No association between XMRV/pMLV and chronic fatigue syndrome

The causes of chronic fatigue syndrome (CFS) have long eluded scientists. In 2009, a paper in the journal Science linked the syndrome-sometimes called myalgic encephalomyelitis (ME)-to infection with a mouse retrovirus called XMRV (xenotropic murine leukemia virus (MLV)-related virus).

18 Sep 2012

Hemerus Medical’s SOLX red blood cell additive receives world's first CE Marking

Hemerus Medical, LLC, a Minnesota-based company that develops innovative technologies for the collection, processing, preservation, and storage of blood products announced that it has received the world's first CE Marking for a 56 day red blood cell storage solution – the SOLX red blood cell additive (AS-7).

18 Sep 2012

HSS recognizes Kaiser Permanente Colorado as a 2012 Hypertension Control Champion

Today, U.S. Department of Health and Human Services Secretary Kathleen Sebelius recognized Kaiser Permanente Colorado as a 2012 Million Hearts Hypertension Control Champion. Million Hearts is a national public-private initiative of the U.S. Department of Health and Human Services.

18 Sep 2012

Renal denervation given the thumbs up by researchers

Catheter-based renal denervation is a cost-effective strategy for resistant hypertension that may result in lower cardiovascular morbidity and mortality, a modeling prediction suggests.

17 Sep 2012

Novel classification system could improve management of facial trauma

A novel scoring system based on the “best” elements of four existing systems can successfully differentiate injuries of patients with complex facial fractures, improving discrimination between severe injuries, report UK researchers.

17 Sep 2012

Refinements in gene therapy prove beneficial for ‘bubble babies’

Results from a long-term study published in Blood show that adding a low dose of chemotherapy prior to gene therapy can help improve outcomes in children with adenosine deaminase-deficient severe combined immunodeficiency.

17 Sep 2012

Type 2 diabetes mellitus patients are at increased risk for cardiovascular disease

LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced the publication of results from a clinical study in the American Journal of Cardiology suggesting that despite having cholesterol levels considered acceptable by today's clinical standards, patients with Type 2 diabetes mellitus (T2DM) are at increased risk for cardiovascular disease-related events.

17 Sep 2012

NIH awards ASC grant to study ASC-101-treated amniotic fluid-derived stem cells in compartment syndrome

America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.

17 Sep 2012

Researchers identify gene mutations in Wolfram syndrome that affects insulin-secreting beta cells

The rare disorder Wolfram syndrome is caused by mutations in a single gene, but its effects on the body are far reaching. The disease leads to diabetes, hearing and vision loss, nerve cell damage that causes motor difficulties, and early death.

17 Sep 2012

Risks of antidiabetic drug substantially overrated for patients with reduced kidney function

The antidiabetic drug metformin is not prescribed for patients with reduced kidney function because the risk of adverse effects has been regarded as unacceptably high. A study at Sahlgrenska Academy, University of Gothenburg, Sweden, has found that the risks have been substantially overrated. As a result, many more patients with diabetes may be able to enjoy the benefits of the medication.

17 Sep 2012

New method to precisely predict premature birth

Babies born early run a greater risk of serious complications. The researchers at the Sahlgrenska Academy, University of Gothenburg, Sweden, have now developed a method to predict if pregnant women with preterm contractions will give birth within seven days. The method offers new possibilities to delay delivery and prepare care for the premature baby.

17 Sep 2012

Biocompatibles, Philips to develop new treatment protocol for trans-arterial embolization

Royal Philips Electronics and Biocompatibles, a BTG international group company, announced a collaboration to advance the use of image guidance to control the delivery of beads during the arterial embolization of hypervascularized tumors today at the annual CIRSE (Cardiovascular and Interventional Radiological Society of Europe) meeting.

15 Sep 2012

MIT engineers use ultrasound waves to enhance permeability of skin to drugs

Using ultrasound waves, MIT engineers have found a way to enhance the permeability of skin to drugs, making transdermal drug delivery more efficient. This technology could pave the way for noninvasive drug delivery or needle-free vaccinations, according to the researchers.

15 Sep 2012

Blood News and Research

No link between low-level electromagnetic field exposure from mobile phones and health risks

ProImmune launches ProStorm in vitro cytokine release assay

Fall prediction and prevention technology: an interview with Rob Goudswaard and Heribert Baldus from Philips

Two abnormalities associated with cystic fibrosis-related diabetes

Researchers to probe causes, treatments of toxic reactions in blood plasma

Positive data from Aprea’s APR-246 Phase I/II study on blood or prostate cancer

New light-based technique demonstrates that toxic proteins build up gradually in blood cells

No association between XMRV/pMLV and chronic fatigue syndrome

Hemerus Medical’s SOLX red blood cell additive receives world's first CE Marking

HSS recognizes Kaiser Permanente Colorado as a 2012 Hypertension Control Champion

Renal denervation given the thumbs up by researchers

Novel classification system could improve management of facial trauma

Refinements in gene therapy prove beneficial for ‘bubble babies’

Type 2 diabetes mellitus patients are at increased risk for cardiovascular disease

NIH awards ASC grant to study ASC-101-treated amniotic fluid-derived stem cells in compartment syndrome

Researchers identify gene mutations in Wolfram syndrome that affects insulin-secreting beta cells

Risks of antidiabetic drug substantially overrated for patients with reduced kidney function

New method to precisely predict premature birth

Biocompatibles, Philips to develop new treatment protocol for trans-arterial embolization

MIT engineers use ultrasound waves to enhance permeability of skin to drugs

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Latest News